Pgim India Healthcare Fund
PGIM India Mutual Fund Β· FM: Puneet Pal, Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma Β· INF663L01Z45 Β· Direct
NAV βΉ12.56 AUM βΉ103 Cr as of 22 Sep 2026
Latest available portfolio Β· Retrieved: 8-Aug-2026 11:29 PM IST Β· Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +0.2% | +9.4% | +27.9% | +24.7% | β | β | 7/234 | 0.96% |
Equity allocation
96.90%
Non-equity allocation (combined)
3.10%
All Equity Holdings (30) latest available
| # | Company | Value (βΉ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 11.2 | 10.86% | β |
| 2 | Divi's Laboratories Ltd | 9.4 | 9.14% | β |
| 3 | Max Healthcare Institute Ltd Ordinary Shares | 6.7 | 6.52% | β |
| 4 | Aster DM Quality Care Ltd Ordinary Shares | 6.6 | 6.41% | β |
| 5 | J.B. Chemicals & Pharmaceuticals Ltd | 6.6 | 6.40% | β |
| 6 | Ajanta Pharma Ltd | 5.7 | 5.56% | β |
| 7 | Mankind Pharma Ltd | 5.4 | 5.19% | β |
| 8 | Krishna Institute of Medical Sciences Ltd | 4.3 | 4.12% | β |
| 9 | Rubicon Research Ltd | 4.1 | 3.99% | β |
| 10 | Neuland Laboratories Ltd | 3.3 | 3.19% | β |
| 11 | Dr. Lal PathLabs Ltd | 3.2 | 3.10% | β |
| 12 | Navin Fluorine International Ltd | 3.2 | 3.09% | β |
| 13 | Dr Reddy's Laboratories Ltd | 2.7 | 2.63% | β |
| 14 | Sai Life Sciences Ltd | 2.7 | 2.60% | β |
| 15 | Torrent Pharmaceuticals Ltd | 2.7 | 2.58% | β |
| 16 | Cipla Ltd | 2.6 | 2.57% | β |
| 17 | Abbott India Ltd | 2.6 | 2.56% | β |
| 18 | Jupiter Life Line Hospitals Ltd | 2.1 | 2.06% | β |
| 19 | Anthem Biosciences Ltd | 2.1 | 2.05% | β |
| 20 | Global Health Ltd | 1.9 | 1.85% | β |
| 21 | Pfizer Ltd | 1.7 | 1.65% | β |
| 22 | Zydus Lifesciences Ltd | 1.5 | 1.44% | β |
| 23 | Fortis Healthcare Ltd | 1.4 | 1.41% | β |
| 24 | Lupin Ltd | 1.4 | 1.33% | β |
| 25 | ICICI Lombard General Insurance Co Ltd | 1.1 | 1.03% | β |
| 26 | Dr Agarwalβs Health Care Ltd | 1.0 | 0.97% | β |
| 27 | Orchid Pharma Ltd | 1.0 | 0.97% | β |
| 28 | Lenskart Solutions Ltd | 0.7 | 0.67% | β |
| 29 | Dr Agarwal'S Eye Hospital Ltd | 0.5 | 0.49% | β |
| 30 | Sagility Ltd | 0.5 | 0.47% | β |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.